This review summarizes current utilization of anti-HER2 targeted therapy across several non-breast solid tumors in the setting of advanced disease.
Hanh Bui, PharmD
Advertisement
Articles by Hanh Bui, PharmD
Advertisement
Latest Updated Articles
A Review of Anti-HER2 Targeted Agents in Non-Breast Solid TumorsPublished: February 14th 2024 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times - Pharmacy Practice News and Expert Insights
1
Bacteria and Fungi in the Mouth Found to Drive Pancreatic Cancer Risk
2
Pfizer Agrees to Lower Certain Drug Prices in US, Aligning With ‘Most-Favored Nation’ Plan
3
Expert: Pharmacists Guide the Future of Gene Therapy in Oncology and Hematology
4
Op-Ed: Why Pharmacy Benefits Need a New Approach
5
